Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis.
Cunnane
Gaye
G
University of California, San Francisco, and VA Medical Center, San Francisco, California, USA. gayecunnane@hotmail.com
Warnock
Martha
M
Fye
Kenneth H
KH
Daikh
David I
DI
D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000473:pathology; D004359:Drug Therapy, Combination; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007555:Isoxazoles / Q000627:therapeutic use; D000077339:Leflunomide; D008297:Male; D008875:Middle Aged; D013902:Radiography, Thoracic; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins / Q000009:adverse effects*; D012218:Rheumatoid Nodule / Q000139:chemically induced* / Q000000981:diagnostic imaging; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014657:Vasculitis / Q000139:chemically induced* / Q000473:pathology
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins; D000077339:Leflunomide; D000068800:Etanercept